Expression of the IGF axis is decreased in local prostate cancer but enhanced after benign prostate epithelial differentiation and TGF-β treatment

American Journal of Pathology

Volumn 179, Issue 6, 2011, Pages 2905-2919

  Massoner, Petra ^a   Ladurner Rennau, Michael ^a   Heidegger, Isabel ^a   Kloss Brandstätter, Anita ^a   Summerer, Monika ^a   Reichhart, Eva ^a   Schfer, Georg ^a   Klocker, Helmut ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN LIKE GROWTH FACTOR RECEPTOR 2; INSULIN RECEPTOR; MESSENGER RNA; SOMATOMEDIN; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN BINDING PROTEIN 4; SOMATOMEDIN BINDING PROTEIN 5; SOMATOMEDIN BINDING PROTEIN 6; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; SOMATOMEDIN RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CANCER TISSUE; CONTROLLED STUDY; DOWN REGULATION; EPITHELIUM CELL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE INDUCTION; HUMAN; HUMAN CELL; HUMAN TISSUE; LASER CAPTURE MICRODISSECTION; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE EPITHELIUM; STROMA CELL; TISSUE DIFFERENTIATION;

CELL DIFFERENTIATION; CELLS, CULTURED; DOWN-REGULATION; EPITHELIAL CELLS; HUMANS; IMMUNOLOGIC TECHNIQUES; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; MALE; PROSTATE; PROSTATIC NEOPLASMS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, SOMATOMEDIN; RNA, MESSENGER; SOMATOMEDINS; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 81255124247     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2011.08.026     Document Type: Article

References (51)

1. A. Gualberto, and M. Pollak Emerging role of insulin-like growth factor receptor inhibitors in oncology: early clinical trial results and future directions Oncogene 28 2009 3009 3021
2. I. Heidegger, A. Pircher, H. Klocker, and P. Massoner Targeting the insulin-like growth factor network in cancer therapy Cancer Biol Ther 11 2011 701 707
3. Pfizer Pfizer Discontinues A Phase 3 Trial Of Figitumumab In Non-Small Cell Lung Cancer (NSCLC) For Futility [press release] December 29, 2009 http://www.pfizer.com/news/press-releases/pfizer-press-release-archive.jsp#guid= 20091229005376en&source=RSS-2009&page=1
4. Pfizer Pfizer Discontinues A Phase 3 Study Of Figitumumab In Previously Treated Patients With Advanced Non-Small Cell Lung Cancer [press release] March 11, 2010 http://www.pfizer.com/news/press-releases/pfizer-press-release-archive. jsp#guid=20100311006790en&source=RSS-2010&page=9
5. J. Jassem, C. Langer, D. Karp, T. Mok, R. Benner, and S. Green Randomized, open label, phase III trial of figitumumab in combination with paclitaxel and carboplatin versus paclitaxel and carboplatin in patients with non-small cell lung cancer (NSCLC) J Clin Oncol 28 2010 2010
6. M. Pollak Insulin and insulin-like growth factor signalling in neoplasia Nat Rev Cancer 8 2008 915 928
7. P. Massoner, M. Ladurner-Rennau, I.E. Eder, and H. Klocker Insulin-like growth factors and insulin control a multifunctional signalling network of significant importance in cancer Br J Cancer 103 2010 1479 1484
8. D. LeRoith, and C.T. Roberts Jr. The insulin-like growth factor system and cancer Cancer Lett 195 2003 127 137 (Pubitemid 36588961)
9. G. Pandini, F. Frasca, R. Mineo, L. Sciacca, R. Vigneri, and A. Belfiore Insulin/insulin-like growth factor I hybrid receptors have different biological characteristics depending on the insulin receptor isoform involved J Biol Chem 277 2002 39684 39695 (Pubitemid 35190951)
10. M. Kawada, H. Inoue, T. Masuda, and D. Ikeda Insulin-like growth factor I secreted from prostate stromal cells mediates tumor-stromal cell interactions of prostate cancer Cancer Res 66 2006 4419 4425
11. M. Parrizas, and D. LeRoith Insulin-like growth factor-1 inhibition of apoptosis is associated with increased expression of the bcl-xL gene product Endocrinology 138 1997 1355 1358 (Pubitemid 27089798)
12. M.M. Marelli, R.M. Moretti, P. Procacci, M. Motta, and P. Limonta Insulin-like growth factor-I promotes migration in human androgen-independent prostate cancer cells via the alphavbeta3 integrin and PI3-K/Akt signaling Int J Oncol 28 2006 723 730
13. J.M. Connolly, and D.P. Rose Regulation of DU145 human prostate cancer cell proliferation by insulin-like growth factors and its interaction with the epidermal growth factor autocrine loop Prostate 24 1994 167 175 (Pubitemid 24122065)
14. M.K. Tennant, J.B. Thrasher, P.A. Twomey, R.H. Drivdahl, R.S. Birnbaum, and S.R. Plymate Protein and messenger ribonucleic acid (mRNA) for the type 1 insulin-like growth factor (IGF) receptor is decreased and IGF-II mRNA is increased in human prostate carcinoma compared to benign prostate epithelium J Clin Endocrinol Metab 81 1996 3774 3782 (Pubitemid 26339953)
15. G.O. Hellawell, G.D. Turner, D.R. Davies, R. Poulsom, S.F. Brewster, and V.M. Macaulay Expression of the type 1 insulin-like growth factor receptor is up-regulated in primary prostate cancer and commonly persists in metastatic disease Cancer Res 62 2002 2942 2950 (Pubitemid 34525783)
16. Y. Liao, U. Abel, R. Grobholz, A. Hermani, L. Trojan, P. Angel, and D. Mayer Up-regulation of insulin-like growth factor axis components in human primary prostate cancer correlates with tumor grade Hum Pathol 36 2005 1186 1196 (Pubitemid 41540395)
17. A. Chott, Z. Sun, D. Morganstern, J. Pan, T. Li, M. Susani, I. Mosberger, M.P. Upton, G.J. Bubley, and S.P. Balk Tyrosine kinases expressed in vivo by human prostate cancer bone marrow metastases and loss of the type 1 insulin-like growth factor receptor Am J Pathol 155 1999 1271 1279 (Pubitemid 29488934)
18. M.E. Cox, M.E. Gleave, M. Zakikhani, R.H. Bell, E. Piura, E. Vickers, M. Cunningham, O. Larsson, L. Fazli, and M. Pollak Insulin receptor expression by human prostate cancers Prostate 69 2009 33 40
19. W. Horninger, A. Reissigl, H. Rogatsch, H. Volgger, M. Studen, H. Klocker, and G. Bartsch Prostate cancer screening in the Tyrol Austria: experience and results Eur J Cancer 36 2000 1322 1335
20. V. Kounnis, E. Ioachim, M. Svoboda, A. Tzakos, I. Sainis, T. Thalhammer, G. Steiner, and E. Briasoulis Expression of organic anion-transporting polypeptides 1B3, 1B1, and 1A2 in human pancreatic cancer reveals a new class of potential therapeutic targets Onco Targets Ther 4 2011 27 32
21. Z. Yao, S. Fenoglio, D.C. Gao, M. Camiolo, B. Stiles, T. Lindsted, M. Schlederer, C. Johns, N. Altorki, V. Mittal, L. Kenner, and R. Sordella TGF-beta IL-6 axis mediates selective and adaptive mechanisms of resistance to molecular targeted therapy in lung cancer Proc Natl Acad Sci U S A 107 2010 15535 15540
22. F. Lv, Y. Qiu, Y. Zhang, S. Liu, J. Shi, Y. Liu, and D. Zheng Adeno-associated virus-mediated anti-DR5 chimeric antibody expression suppresses human tumor growth in nude mice Cancer Lett 302 2011 119 127
23. M.V. Cronauer, I.E. Eder, A. Hittmair, G. Sierek, A. Hobisch, Z. Culig, M. Thurnher, G. Bartsch, and H. Klocker A reliable system for the culture of human prostatic cells In Vitro Cell Dev Biol Anim 33 1997 742 744
24. I. Kogan, N. Goldfinger, M. Milyavsky, M. Cohen, I. Shats, G. Dobler, H. Klocker, B. Wasylyk, M. Voller, T. Aalders, J.A. Schalken, M. Oren, and V. Rotter hTERT-immortalized prostate epithelial and stromal-derived cells: an authentic in vitro model for differentiation and carcinogenesis Cancer Res 66 2006 3531 3540
25. D. Bello, M.M. Webber, H.K. Kleinman, D.D. Wartinger, and J.S. Rhim Androgen responsive adult human prostatic epithelial cell lines immortalized by human papillomavirus 18 Carcinogenesis 18 1997 1215 1223 (Pubitemid 28132513)
26. P. Massoner, P. Haag, C. Seifarth, A. Jurgeit, H. Rogatsch, W. Doppler, G. Bartsch, and H. Klocker Insulin-like growth factor binding protein-3 (IGFBP-3) in the prostate and in prostate cancer: local production, distribution and secretion pattern indicate a role in stromal-epithelial interaction Prostate 68 2008 1165 1178
27. R.A. Jones, C.I. Campbell, E.J. Gunther, L.A. Chodosh, J.J. Petrik, R. Khokha, and R.A. Moorehead Transgenic overexpression of IGF-IR disrupts mammary ductal morphogenesis and induces tumor formation Oncogene 26 2007 1636 1644 (Pubitemid 46398739)
28. H.J. Kim, B.C. Litzenburger, X. Cui, D.A. Delgado, B.C. Grabiner, X. Lin, M.T. Lewis, M.M. Gottardis, T.W. Wong, R.M. Attar, J.M. Carboni, and A.V. Lee Constitutively active type I insulin-like growth factor receptor causes transformation and xenograft growth of immortalized mammary epithelial cells and is accompanied by an epithelial-to-mesenchymal transition mediated by NF-kappaB and snail Mol Cell Biol 27 2007 3165 3175 (Pubitemid 46581327)
29. S.R. Plymate, V.L. Bae, L. Maddison, L.S. Quinn, and J.L. Ware Reexpression of the type 1 insulin-like growth factor receptor inhibits the malignant phenotype of simian virus 40 T antigen immortalized human prostate epithelial cells Endocrinology 138 1997 1728 1735 (Pubitemid 27137128)
30. B.W. Sutherland, S.E. Knoblaugh, P.J. Kaplan-Lefko, F. Wang, M. Holzenberger, and N.M. Greenberg Conditional deletion of insulin-like growth factor-I receptor in prostate epithelium Cancer Res 68 2008 3495 3504
31. S. Dalrymple, L. Antony, Y. Xu, A.R. Uzgare, J.T. Arnold, J. Savaugeot, L.J. Sokoll, A.M. De Marzo, and J.T. Isaacs Role of notch-1 and E-cadherin in the differential response to calcium in culturing normal versus malignant prostate cells Cancer Res 65 2005 9269 9279 (Pubitemid 41507993)
32. D.M. Peehl, and T.A. Stamey Serum-free growth of adult human prostatic epithelial cells In Vitro Cell Dev Biol 22 1986 82 90 (Pubitemid 16167977)
33. L.A. Garraway, D. Lin, S. Signoretti, D. Waltregny, J. Dilks, N. Bhattacharya, and M. Loda Intermediate basal cells of the prostate: in vitro and in vivo characterization Prostate 55 2003 206 218 (Pubitemid 36532400)
34. A.Y. Liu, and D.M. Peehl Characterization of cultured human prostatic epithelial cells by cluster designation antigen expression Cell Tissue Res 305 2001 389 397 (Pubitemid 34212132)
35. X. Li, Y. Wang, A.R. Sharif-Afshar, C. Uwamariya, A. Yi, K. Ishii, S.W. Hayward, R.J. Matusik, and N.A. Bhowmick Urothelial transdifferentiation to prostate epithelia is mediated by paracrine TGF-beta signaling Differentiation 77 2009 95 102
36. G. Untergasser, R. Gander, H. Rumpold, E. Heinrich, E. Plas, and P. Berger TGF-beta cytokines increase senescence-associated beta-galactosidase activity in human prostate basal cells by supporting differentiation processes, but not cellular senescence Exp Gerontol 38 2003 1179 1188 (Pubitemid 37324429)
37. R. Rajah, B. Valentinis, and P. Cohen Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-beta1 on programmed cell death through a p53- and IGF-independent mechanism J Biol Chem 272 1997 12181 12188 (Pubitemid 27202802)
38. R.J. Romanelli, A.P. LeBeau, C.G. Fulmer, D.A. Lazzarino, A. Hochberg, and T.L. Wood Insulin-like growth factor type-I receptor internalization and recycling mediate the sustained phosphorylation of Akt J Biol Chem 282 2007 22513 22524 (Pubitemid 47267366)
39. G. Levkowitz, H. Waterman, E. Zamir, Z. Kam, S. Oved, W.Y. Langdon, L. Beguinot, B. Geiger, and Y. Yarden c-Cbl/Sli-1 regulates endocytic sorting and ubiquitination of the epidermal growth factor receptor Genes Dev 12 1998 3663 3674 (Pubitemid 29019647)
40. H. Yaziji, and T. Barry Diagnostic immunohistochemistry: what can go wrong Adv Anat Pathol 13 2006 238 246 (Pubitemid 44439978)
41. C.R. Taylor, and R.M. Levenson Quantification of immunohistochemistryissues concerning methods, utility and semiquantitative assessment II Histopathology 49 2006 411 424 (Pubitemid 44401549)
42. C. Sell, M. Rubini, R. Rubin, J.P. Liu, A. Efstratiadis, and R. Baserga Simian virus 40 large tumor antigen is unable to transform mouse embryonic fibroblasts lacking type 1 insulin-like growth factor receptor Proc Natl Acad Sci U S A 90 1993 11217 11221 (Pubitemid 23354400)
43. C.J. Ryan, C.M. Haqq, J. Simko, D.F. Nonaka, J.M. Chan, V. Weinberg, E.J. Small, and I.D. Goldfine Expression of insulin-like growth factor-1 receptor in local and metastatic prostate cancer Urol Oncol 25 2007 134 140 (Pubitemid 46349758)
44. B.W. Turney, G.D. Turner, S.F. Brewster, and V.M. Macaulay Serial analysis of resected prostate cancer suggests up-regulation of type 1 IGF receptor with disease progression BJU Int 107 2010 1488 1499
45. M. Goya, S. Miyamoto, K. Nagai, Y. Ohki, K. Nakamura, K. Shitara, H. Maeda, T. Sangai, K. Kodama, Y. Endoh, G. Ishii, T. Hasebe, H. Yonou, T. Hatano, Y. Ogawa, and A. Ochiai Growth inhibition of human prostate cancer cells in human adult bone implanted into nonobese diabetic/severe combined immunodeficient mice by a ligand-specific antibody to human insulin-like growth factors Cancer Res 64 2004 6252 6258 (Pubitemid 39129428)
46. H. Schayek, H. Seti, N.M. Greenberg, S. Sun, H. Werner, and S.R. Plymate Differential regulation of insulin-like growth factor-I receptor gene expression by wild type and mutant androgen receptor in prostate cancer cells Mol Cell Endocrinol 323 2010 239 245
47. P.J. Kaplan, S. Mohan, P. Cohen, B.A. Foster, and N.M. Greenberg The insulin-like growth factor axis and prostate cancer: lessons from the transgenic adenocarcinoma of mouse prostate (TRAMP) model Cancer Res 59 1999 2203 2209 (Pubitemid 29217686)
48. T. Aleksic, M.M. Chitnis, O.V. Perestenko, S. Gao, P.H. Thomas, G.D. Turner, A.S. Protheroe, M. Howarth, and V.M. Macaulay Type 1 insulin-like growth factor receptor translocates to the nucleus of human tumor cells Cancer Res 70 2010 6412 6419
49. A.G. Renehan, M. Zwahlen, C. Minder, S.T. O'Dwyer, S.M. Shalet, and M. Egger Insulin-like growth factor (IGF)-I IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis Lancet 363 2004 1346 1353 (Pubitemid 38529873)
50. B. Sehat, A. Tofigh, Y. Lin, E. Trocme, U. Liljedahl, J. Lagergren, and O. Larsson SUMOylation mediates the nuclear translocation and signaling of the IGF-1 receptor Sci Signal 3 2010 ra10
51. R. Shi, H.J. Berkel, and H. Yu Insulin-like growth factor-I and prostate cancer: a meta-analysis Br J Cancer 85 2001 991 996 (Pubitemid 33016002)